Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Minority Interest (2016)

Historic Minority Interest for United Therapeutics (UTHR) over the last 8 years, with Q4 2016 value amounting to $10.9 million.

  • United Therapeutics' Minority Interest changed 0.0% to $10.9 million in Q4 2016 from the same period last year, while for Dec 2016 it was $10.9 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $10.9 million for FY2016, which is 0.0% changed from last year.
  • According to the latest figures from Q4 2016, United Therapeutics' Minority Interest is $10.9 million, which was down 0.0% from $10.9 million recorded in Q4 2015.
  • In the past 5 years, United Therapeutics' Minority Interest registered a high of $10.9 million during Q4 2015, and its lowest value of $10.9 million during Q1 2012.
  • For the 5-year period, United Therapeutics' Minority Interest averaged around $10.9 million, with its median value being $10.9 million (2012).
  • As far as peak fluctuations go, United Therapeutics' Minority Interest changed by 0.0% in 2012, and later grew by 16.54% in 2015.
  • Quarter analysis of 5 years shows United Therapeutics' Minority Interest stood at $10.9 million in 2012, then changed by 0.0% to $10.9 million in 2013, then changed by 0.0% to $10.9 million in 2014, then increased by 0.17% to $10.9 million in 2015, then changed by 0.0% to $10.9 million in 2016.
  • Its Minority Interest stands at $10.9 million for Q4 2016, versus $10.9 million for Q4 2015 and $10.9 million for Q3 2015.